Progressive systemic sclerosis - Report of two cases
N Malathi+4 more
doaj
The Prevalence and Severity of Pain in Patients With Systemic Sclerosis
ABSTRACT We investigated pain prevalence and severity in systemic sclerosis (SSc) and patient–physician perceptions. This was an internet‐based survey that compared perceptions of pain type, location, severity, associated factors between patients with SSc and physicians, and pain treatment prescription patterns in Japan in March 2023.
Sei‐ichiro Motegi+6 more
wiley +1 more source
ABSTRACT IgG4, the least abundant IgG subclass in humans, is increasingly recognised for its involvement in allergic and autoimmune pathologies. Its unique properties, such as the tendency to form half‐molecules (one heavy chain and one light chain) and its generally non‐inflammatory nature, distinguish it from other IgG subclasses.
Louisa Tedesco+8 more
wiley +1 more source
A case of visceral leishmaniasis mimicking connective tissue disease
Rheumatology &Autoimmunity, EarlyView.
Yucui Li+4 more
wiley +1 more source
ABSTRACT Background Recent advances now allow detection of brain‐specific proteins in blood, including neurofilament light chain (NfL), a marker of axonal pathology, and glial fibrillary acidic protein (GFAP), indicative of astrocytic activation. Given the evidence of astroglial pathology and neuronal dysfunction in bipolar disorder, and ongoing ...
Matthew J. Y. Kang+15 more
wiley +1 more source
Dexamethasone-cyclophosphamide pulse therapy in progressive systemic sclerosis
Viswanath Vishalakshi+3 more
doaj
Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]
Jimenez, Sergio A., Rosenbloom, Joel
core +1 more source
A case report: The efficacy of pirfenidone in a Chinese patient with progressive systemic sclerosis-associated interstitial lung disease: A CARE-compliant article. [PDF]
Huang H+5 more
europepmc +1 more source
CCR5 predicts neurotoxicity in CAR‐T‐cell therapy
Patients undergoing chimeric antigen receptor T (CAR T)‐cell therapy are at risk of developing immune effector cell‐associated neurotoxicity syndrome (ICANS). We observed an upregulation of CCR5 and CCR2 expression in CD4+ T cells among patients who developed ICANS.
Ayal Rozenberg+12 more
wiley +1 more source
Progressive systemic sclerosis with intraoral manifestations: A case report and review.
Srivastava R+3 more
europepmc +1 more source